［1］Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention:GINA executive summary［J］. Eur Respir J, 2008, 31（1）:143-178.
［2］Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: Isaac phases one and three repeat multicountry crosssectional surveys［J］. Lancet, 2006, 368（9537）:733-743.
［3］Brutsche MH, Downs SH, Schindler C, Gerbase MW,Schwartz J, Frey M, et al.Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: Sapaldia Cohort Study［J］. Thorax, 2006, 61（8）:671-677.
［4］Harmanci K, Bakirtas A, Turktas I.Factors affecting bronchial hyperreactivity in asthmatic children［J］. J Asthma, 2008, 45（9）：730-734.
［5］Pallasaho P, Ronmark E, Haahtela T, Sovijarvi AR, Lundback B. Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland［J］. Clin Exp Allergy, 2006, 36（4）:503-509.
［7］Holt PG, Thomas WR. Sensitization to airborne environmental allergens: unresolved issues［J］. Nat Immunol, 2005, 6（10）:957-960.
［8］Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hyperresponsiveness and mortality from chronic obstructive pulmonary disease: a cohort study［J］. Lancet, 2000, 356（9238）:1313-1317.
［9］National Heart, Lung and Blood Institute. Global strategy for asthma management and prevention. WHO/NHLBI Workshop Report, 2006：61-63.
［10］Van Den Berge M, Meijer RJ, Kerstjens HA, de Reus DM,Koeter GH, Kauffman HF, et al. Pc(20) adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than pc(20) methacholine［J］. Am J Respir Crit Care Med, 2001, 163（7）:1546-1550.
［11］Byrne PM,Gauvreau GM,Brannan JD. Provoked models of asthma: what have we learnt?［J］. Clin Exp Allergy, 2009, 39（2）: 181-192.
［12］Regamey N, Ochs M, Hilliard TN, Muhlfeld C, Cornish N, Fleming L. Increased airway smooth muscle mass in children with asthma, cystic fibrosis and non-cystic fibrosis bronchiectasis［J］. Am J Respir Crit Care Med, 2008, 177（8）:837-843.
［14］Zhou L, Li J, Goldsmith AM, Newcomb DC, Giannola DM, Vosk RG, et al.Human bronchial smooth muscle cell lines show a hypertrophic phenotype typical of sever asthma［J］.Am J Respir Crit Care Med, 2003, 169（6）:703-711.
［15］Benayoun L, Druilhe A, Dombret MC, Aubier M,Pretolani M. Airway structural alterations selectively associated with severe asthma［J］. Am J Respir Crit Care Med, 2003, 167（10）:1360-1368.
［16］Brown NJ, Salome CM, Berend N, Thorpe CW, King GG. Airway distensibility in asthmatic and healthy adults measured by forced oscillation technique［J］. Am J Respir Crit Care Med, 2007, 176（2）:129-137.
［17］McClean M, Matheson MJ, McKay K, Johnson PRA, Rynell AC, Ammit AJ, et al. Low lung volume alters contractile properties of airway smooth muscle in sheep［J］. Eur Respir J, 2003, 22（1）: 50-56.
［18］Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S. Bronchial thermoplasty for asthma［J］. Am J Respir Crit Care Med, 2006, 173（9）: 965-969.
［19］Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary diseas［J］. Proc Am Thorac Soc, 2004, 1（3）:176-183.
［20］Kasahara K, Shiba K, Ozawa T, Okuda K, Adachi M. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma［J］. Thorax, 2002, 57（3）: 242-246.
［21］Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma［J］. Am J Respir Crit Care Med, 2003, 168（8）:983-988.
［22］McParland BE,Macklem PT, Pare PD. Airway wall remodeling: friend or foe?［J］. J Appl Physiol, 2003, 95（1）: 426-434.
［23］Simpson JL, Scott RJ, Boyle MJ, Gibson PG. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma［J］. Am J Respir Crit Care Med, 2005, 172（5）: 559-565.
［24］Downie SR, Salome CM, Verbanck S, Thompson BR,Berend N, King GG. Ventilation heterogeneity is a major-determinant of airway hyperresponsiveness in asthma, independent of airway inflammation［J］. Thorax, 2007, 62（8）: 684-689.
［25］Brightling CE, Bradding P, Symon FA, Holgate ST,Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma［J］. N Engl J Med, 2002, 346（22）:1699-1705.
［26］Halvor S, Devendra K. Naturally occurring and lnducible t-regulatory cells modulating immune response in allergic asthma［J］. Am J Respir Crit Care Med, 2009, 180（3）:211-225.
